Literature DB >> 7761411

Surfactant protein a promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus.

J F Downing1, R Pasula, J R Wright, H L Twigg, W J Martin.   

Abstract

The incidence of tuberculosis is increasing on a global scale, in part due to its strong association with human immunodeficiency virus (HIV) infection. Attachment of Mycobacterium tuberculosis to its host cell, the alveolar macrophage (AM), is an important early step in the pathogenesis of infection. Bronchoalveolar lavage of HIV-infected individuals demonstrated the presence of a factor which significantly enhances the attachment of tubercle bacilli to AMs 3-fold relative to a normal control population. This factor is surfactant protein A (SP-A). SP-A levels are increased in the lungs of HIV-infected individuals. SP-A levels and attachment of M. tuberculosis to AMs inversely correlate with peripheral blood CD4 lymphocyte counts. Elevated concentrations of SP-A during the progression of HIV infection may represent an important nonimmune risk factor for acquiring tuberculosis, even before significant depletion of CD4 lymphocytes in the peripheral blood occurs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7761411      PMCID: PMC41804          DOI: 10.1073/pnas.92.11.4848

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

Review 1.  Tuberculosis in the United States.

Authors:  H L Rieder; G M Cauthen; G D Kelly; A B Bloch; D E Snider
Journal:  JAMA       Date:  1989-07-21       Impact factor: 56.272

Review 2.  Pulmonary surfactant metabolism.

Authors:  J R Wright; S Hawgood
Journal:  Clin Chest Med       Date:  1989-03       Impact factor: 2.878

Review 3.  Tuberculosis and human immunodeficiency virus infection in developing countries.

Authors:  A D Harries
Journal:  Lancet       Date:  1990-02-17       Impact factor: 79.321

4.  Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3.

Authors:  L S Schlesinger; C G Bellinger-Kawahara; N R Payne; M A Horwitz
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

5.  Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR- and CR1-mediated phagocytosis.

Authors:  A J Tenner; S L Robinson; J Borchelt; J R Wright
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

6.  Nosocomial epidemic of active tuberculosis among HIV-infected patients.

Authors:  G Di Perri; M Cruciani; M C Danzi; R Luzzati; G De Checchi; M Malena; S Pizzighella; R Mazzi; M Solbiati; E Concia
Journal:  Lancet       Date:  1989 Dec 23-30       Impact factor: 79.321

7.  Surfactant apoprotein Mr = 26,000-36,000 enhances uptake of liposomes by type II cells.

Authors:  J R Wright; R E Wager; S Hawgood; L Dobbs; J A Clements
Journal:  J Biol Chem       Date:  1987-02-25       Impact factor: 5.157

8.  Increased recovery of surfactant protein A in AIDS-related pneumonia.

Authors:  D S Phelps; R M Rose
Journal:  Am Rev Respir Dis       Date:  1991-05

9.  Macromolecular organization of natural and recombinant lung surfactant protein SP 28-36. Structural homology with the complement factor C1q.

Authors:  T Voss; H Eistetter; K P Schäfer; J Engel
Journal:  J Mol Biol       Date:  1988-05-05       Impact factor: 5.469

10.  The human mannose-binding protein functions as an opsonin.

Authors:  M Kuhlman; K Joiner; R A Ezekowitz
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  28 in total

1.  Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite.

Authors:  J Hickman-Davis; J Gibbs-Erwin; J R Lindsey; S Matalon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 2.  Assembly of the phagocyte NADPH oxidase.

Authors:  William M Nauseef
Journal:  Histochem Cell Biol       Date:  2004-08-04       Impact factor: 4.304

3.  Variants of the SFTPA1 and SFTPA2 genes and susceptibility to tuberculosis in Ethiopia.

Authors:  S Malik; C M T Greenwood; T Eguale; A Kifle; J Beyene; A Habte; A Tadesse; H Gebrexabher; S Britton; E Schurr
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

Review 4.  Macrophage receptors for Mycobacterium tuberculosis.

Authors:  J D Ernst
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

Review 5.  C-type lectins with a sweet spot for Mycobacterium tuberculosis.

Authors:  G Lugo-Villarino; D Hudrisier; A Tanne; O Neyrolles
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

6.  Human lung surfactant protein A exists in several different oligomeric states: oligomer size distribution varies between patient groups.

Authors:  T P Hickling; R Malhotra; R B Sim
Journal:  Mol Med       Date:  1998-04       Impact factor: 6.354

7.  The role of CD38 in Fcγ receptor (FcγR)-mediated phagocytosis in murine macrophages.

Authors:  John Kang; Kwang-Hyun Park; Jwa-Jin Kim; Eun-Kyeong Jo; Myung-Kwan Han; Uh-Hyun Kim
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

8.  Invasion activity of a Mycobacterium tuberculosis peptide presented by the Escherichia coli AIDA autotransporter.

Authors:  Nicola Casali; Marc Konieczny; M Alexander Schmidt; Lee W Riley
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 9.  The role of surfactant-associated protein A in pulmonary host defense.

Authors:  V L Shepherd; J P Lopez
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

10.  Lipid-restricted recognition of mycobacterial lipoglycans by human pulmonary surfactant protein A: a surface-plasmon-resonance study.

Authors:  Stéphane Sidobre; Germain Puzo; Michel Rivière
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.